Skip to main content
Published locations for Relapsed/refractory AML: MIV alone or in combination with venetoclax shows promise in phase 1
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Relapsed/refractory AML: MIV alone or in combination with venetoclax shows promise in phase 1
User login
Username
Password
Reset your password
/content/relapsed/refractory-aml-miv-alone-or-combination-venetoclax-shows-promise-phase-1
/hematology-oncology/article/241345/aml/relapsed/refractory-aml-miv-alone-or-combination-venetoclax